Close
  Indian J Med Microbiol
 

Table 2: IC50 values of N-aryl enamino amides and dihydropyrimidinethiones vs assessed cancer cell lines. Data are presented as mean ± SEM, n = 3. a and b are designated to the compounds which are more potent (lower IC50 , P ≤ 0.05) than cisplatin and monastrol, respectively.

Table 2: IC<sub>50</sub> values of <i>N</i>-aryl enamino amides and dihydropyrimidinethiones vs assessed cancer cell lines. Data are presented as mean ± SEM, n = 3. <sup>a</sup> and <sup>b</sup> are designated to the compounds which are more potent (lower IC<sub>50</sub> , <i>P</i> ≤ 0.05) than cisplatin and monastrol, respectively.